Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Eye Tracking and Autism in Former Preterm Infants

NCT: NCT07764822 · NOT_YET_RECRUITING

NCT IDNCT07764822
StatusNOT_YET_RECRUITING
Start Date2027-01-04
Completion2028-01-03
SponsorIndiana University (OTHER)
First posted
Last updated

Brief Summary

This is a single center, intervention study of integrating the eye-tracking (ET) biomarker battery into the existing autism evaluation process at the Riley Early Years Program (EYP). Eligible participants referred for autism testing through EYP will undergo a traditional comprehensive diagnostic assessment by an EYP clinical psychologist.

Frequently Asked Questions

What is Eye Tracking and Autism in Former Preterm Infants?

Eye Tracking and Autism in Former Preterm Infants is a clinical trial registered under NCT07764822. Current status: NOT_YET_RECRUITING.

What is the status of NCT07764822?

The current status of NCT07764822 (Eye Tracking and Autism in Former Preterm Infants) is: NOT_YET_RECRUITING.

When did Eye Tracking and Autism in Former Preterm Infants start?

Eye Tracking and Autism in Former Preterm Infants started on 2027-01-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.